⌘K

Login Start Free

Home/Filings/4/0001209191-21-029845

4//SEC Filing

Garber Alan M 4

Accession 0001209191-21-029845

CIK 0000875320other

View on SEC.gov Company Profile

Filed

May 3, 8:00 PM ET

Accepted

May 4, 4:08 PM ET

Size

5.1 KB

Accession

0001209191-21-029845

Insider Transaction Report

Form 4

Period: 2021-05-01

VERTEX PHARMACEUTICALS INC / MAVRTX

Director

Transactions

Award
Stock Option (Right to Buy)
2021-05-01+6,067→ 6,067 total
Exercise: $217.20Exp: 2031-04-30→ Common Stock (6,067 underlying)

Footnotes (1)

[F1]Fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001312907

Filing Metadata

Form type: 4
Filed: May 3, 8:00 PM ET
Accepted: May 4, 4:08 PM ET
Size: 5.1 KB

View on SEC.gov